Showing 1 - 20 results of 4,722 for search '(( _ point decrease ) OR ((( six ((nn decrease) OR (a decrease)) ) OR ( _ web decrease ))))', query time: 0.48s Refine Results
  1. 1

    Fig 5 - by Samuel Hylander (331771)

    Published 2024
    Subjects:
  2. 2

    Fig 1 - by Samuel Hylander (331771)

    Published 2024
    Subjects:
  3. 3

    Fig 2 - by Samuel Hylander (331771)

    Published 2024
    Subjects:
  4. 4

    Fig 6 - by Samuel Hylander (331771)

    Published 2024
    Subjects:
  5. 5
  6. 6

    Fig 4 - by Samuel Hylander (331771)

    Published 2024
    Subjects:
  7. 7
  8. 8

    Fig 3 - by Samuel Hylander (331771)

    Published 2024
    Subjects:
  9. 9
  10. 10

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20